Compare Novartis AG (NVS) vs Pure Storage (P) Price & Performance

Novartis AGTrade

Pure StorageTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Pure Storage — how do they compare? Novartis AG trades at $139.66 (market cap $262.64B), while Pure Storage trades at $98.24 (market cap $33.70B). The key difference: Novartis AG is far larger — about 7.8× Pure Storage's market cap, and Novartis AG pays a 3.44% dividend while Pure Storage pays none. Which is the better fit depends on your goals.

	NVS	P
Market Cap	$262.64B	$33.70B
Sector	Health	Technology
52-Week High	$168.62	$118.16
52-Week Low	$121.80	$56.99
Enterprise Value	$303.97B	$32.92B
Dividend Yield	3.44%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novartis AG

Novartis (NVS) is trading at $137.70, down 13.93% following significant clinical trial setbacks for del-desiran and pelacarsen. The stock shows bearish technical signals with support at $133-$136 and resistance at $140-$143. Fundamentally, the company maintains strong profitability with 74.74% gross margins and 22.5% net income margins, though recent pipeline failures have overshadowed solid financial performance.

While Novartis maintains strong financial fundamentals and reiterated 2025-2030 growth guidance, the recent clinical trial failures create near-term uncertainty. The stock faces pressure from pipeline setbacks but offers value at current levels for long-term investors willing to weather development risks. Analyst consensus remains cautious with 68% hold ratings.

Pure Storage

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis shares plunge 12.5% after two Phase 3 drug trials fail primary goalsPRNewsWire · 19 hours agoBearish Amgen shares drop 10% after Novartis fails cholesterol drug trial, despite Amgen's own cancer trial success.24/7 Wall Street · 1 day agoBearish Novartis shares drop 10% after del-desiran fails Phase 3 trial for myotonic dystrophyProactive Investors · 1 day agoBearish View details →

Everpure joins S&P 500, marking a milestone in its growth and AI-ready data management.PRNewsWire · 1 day agoBullish View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About Pure Storage

Pure Storage develops enterprise data storage and data management systems, primarily using all-flash technology. Its platform supports cloud, AI, analytics, and mission-critical application workloads.